We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+27%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
AUM
$568M
AUM Growth
+$55.3M
Cap. Flow
+$7.09M
Cap. Flow %
1.25%
Top 10 Hldgs %
82.48%
Holding
77
New
5
Increased
9
Reduced
4
Closed
4

Sector Composition

Rank Sector Weight
1 Miscellaneous 37.76%
2 Industrials 28.25%
3 Healthcare 13.73%
4 Technology 6.13%
5 Materials 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
1
SPDR Gold Trust
GLD
$149B
$188M 33.12%
475,000
GPGI
2
GPGI Inc
GPGI
$3.84B
$76.6M 13.48%
3,974,676
+55,210
+1% +$1.1M
RHLD
3
Resolute Holdings Management
RHLD
$1.06B
$66M 11.62%
319,844
-1,569
-0.5% -$232K
LIN icon
4
Linde
LIN
$226B
$32M 5.64%
75,114
-7,000
-9% -$3M
MDXH icon
5
MDxHealth
MDXH
$68.8M
$26.3M 4.64%
7,378,333
SPY icon
6
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$22.2M 3.91%
32,570
DUOT icon
7
Duos Technologies
DUOT
$294M
$18.3M 3.22%
1,627,806
BX icon
8
Blackstone
BX
$107B
$14M 2.46%
90,750
IDN icon
9
Intellicheck
IDN
$57.6M
$13.9M 2.44%
2,073,583
INVE icon
10
Identive
INVE
$66.9M
$11.1M 1.95%
2,884,495
SPGI icon
11
S&P Global
SPGI
$131B
$10.5M 1.84%
20,000
DTIL icon
12
Precision BioSciences
DTIL
$215M
$6.92M 1.22%
1,662,500
+587,500
+55% +$3.33M
EYPT icon
13
EyePoint Inc
EYPT
$386M
$5.78M 1.02%
316,515
+60,000
+23% +$850K
IMMX icon
14
Immix Biopharma
IMMX
$992M
$5.23M 0.92%
1,000,000
+150,000
+18% +$617K
OWLT icon
15
Owlet
OWLT
$146M
$5.02M 0.88%
310,000
+40,000
+15% +$453K
JPM icon
16
JPMorgan Chase
JPM
$951B
$4.83M 0.85%
15,000
LIQT icon
17
LiqTech
LIQT
$18.8M
$4.65M 0.82%
3,182,239
PROK icon
18
ProKidney
PROK
$382M
$4.48M 0.79%
2,000,000
BRFH icon
19
Barfresh Food Group
BRFH
$20.4M
$4.07M 0.72%
1,390,758
WELL icon
20
Welltower
WELL
$172B
$3.71M 0.65%
20,000
FLNT
21
Fluent
FLNT
$111M
$3.43M 0.6%
1,428,571
GNLX icon
22
Genelux
GNLX
$120M
$3.11M 0.55%
714,000
DMAC icon
23
DiaMedica Therapeutics
DMAC
$345M
$3.04M 0.54%
382,317
NMTC icon
24
NeuroOne Medical Technologies
NMTC
$16.1M
$3.03M 0.53%
666,667
TV icon
25
Televisa
TV
$1.45B
$3M 0.53%
1,030,000

Similar funds

Bleichroeder LP's Q4 2025 Portfolio in Review

As of Q4 2025, Bleichroeder LP held 77 positions worth $568M, up 11% from $513M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Bleichroeder LP's Q4 2025 filing shows 5 new, 9 increased, 4 reduced and 4 closed positions. Its largest new stake was Kazia Therapeutics: 400,000 shares worth $2.76M. The largest sale was Linde, an estimated $3M.

By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 38% a quarter earlier, followed by Industrials and Healthcare.

  • Bleichroeder LP's largest Q4 2025 buy was Kazia Therapeutics: 400,000 shares worth $2.76M.
  • Bleichroeder LP added most to Precision BioSciences in Q4 2025, an estimated $3.33M increase.
  • Bleichroeder LP's biggest Q4 2025 reduction was Linde, cutting an estimated $3M.
  • Bleichroeder LP fully exited CompoSecure Inc Warrant in Q4 2025, selling an estimated $1.28M.
  • Bleichroeder LP's ten largest holdings make up 82% of its $568M portfolio in Q4 2025.
  • Bleichroeder LP opened 5 new positions and closed 4 in Q4 2025.
  • Bleichroeder LP's portfolio value rose 11% quarter-over-quarter to $568M.

Based on Bleichroeder LP's 13F filing for Q4 2025, filed 13 Feb 2026.